HRASF(HRASF)
HRASF
No analyst ratings available
No analyst price targets available for HRASF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $12.75B | $12.93B | $13.19B | $12.93B |
| Low | $11.86B | $12.68B | $12.61B | $12.35B |
| High | $13.45B | $13.42B | $13.81B | $13.53B |
| EBITDA Avg | $1.13B | $1.15B | $1.17B | $1.15B |
| Low | $1.05B | $1.12B | $1.12B | $1.10B |
| High | $1.19B | $1.19B | $1.22B | $1.20B |
| EBIT Avg | $642M | $651M | $664M | $651M |
| Low | $597M | $638M | $635M | $622M |
| High | $677M | $676M | $695M | $681M |
| Net Income Avg | $447M | $468M | $488M | $490M |
| Low | $421M | $441M | $460M | $462M |
| High | $474M | $497M | $518M | $520M |
| EPS Avg | $0.31 | $0.32 | $0.33 | $0.33 |
| Low | $0.29 | $0.30 | $0.31 | $0.32 |
| High | $0.32 | $0.34 | $0.35 | $0.35 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 1 / 1 | 2 / 1 |